CompletedPhase 3NCT00485368
Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Studying Marfan syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bayside Health
- Principal Investigator
- Bronwyn A Kingwell, PhDBaker Heart Research Institute
- Intervention
- Coversyl (perindopril)(drug)
- Enrollment
- 17 enrolled
- Eligibility
- 18-40 years · All sexes
- Timeline
- 2004 – 2006
Collaborators
Baker Heart Research Institute · The Alfred
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00485368 on ClinicalTrials.govOther trials for Marfan syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT06786754Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic DiseasesIRCCS Policlinico S. Donato
- ACTIVE NOT RECRUITINGNCT05389865Proximal Aortopathy in Scotland - Epidemiology and Surgical OutcomesGolden Jubilee National Hospital
- RECRUITINGNANCT05809323Marfan Syndrome Moderate Exercise Trial IIBaylor College of Medicine
- RECRUITINGNANCT05838235Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGNANCT05720923Analysis of Muscular Properties in Patients With MFS and EDSIRCCS Policlinico S. Donato
- RECRUITINGNCT05702476Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D AssessmentIRCCS Policlinico S. Donato
- RECRUITINGNANCT04970459Biological Collection for Marfan and Related SyndromesUniversity Hospital, Toulouse
- RECRUITINGNCT05700175Transcriptomic Study of Adult Population With Marfan SyndromeIRCCS Policlinico S. Donato